Showing results (61-70 of 133) with videos related to

Sort By:
Pageof 14
Drug Discoveries & Therapeutics|May 16, 2018
1,2,3-Triazolyl ester of ketorolac (15K): Boosting both heat-endurance and lifespan of C. elegans by down-regulating PAK1 at nM levelsBinh C Nguyen, Sung-A Kim, Seong-Min Won, et al.
Cancer Letters|September 3, 2008
The novel hypoxic cell radiosensitizer, TX-1877 has antitumor activity through suppression of angiogenesis and inhibits liver metastasis on xenograft model of pancreatic cancerKotaro Miyake, Mitsuo Shimada, Masanori Nishioka, et al.
Biochemical and Biophysical Research Communications|December 15, 2011
HlPT-1, a membrane-bound prenyltransferase responsible for the biosynthesis of bitter acids in hopsYusuke Tsurumaru, Kanako Sasaki, Tatsuya Miyawaki, et al.
Experimental Cell Research|April 5, 2012
The novel hypoxic cytotoxin, TX-2098 has antitumor effect in pancreatic cancer; possible mechanism through inhibiting VEGF and hypoxia inducible factor-1α targeted gene expressionKotaro Miyake, Masanori Nishioka, Satoru Imura, et al.
Bioorganic & Medicinal Chemistry Letters|February 18, 2011
Synthesis and photophysical properties of new SNARF derivatives as dual emission pH sensorsEiji Nakata, Yoshijiro Nazumi, Yoshihiro Yukimachi, et al.
Cancer Chemotherapy and Pharmacology|February 14, 2009
Downregulation of matrix metalloprotease-9 and urokinase plasminogen activator by TX-1877 results in decreased tumor growth and metastasis on xenograft model of rectal cancerKotaro Miyake, Mitsuo Shimada, Masanori Nishioka, et al.
Anticancer Research|June 30, 2016
Case Report: GcMAF Treatment in a Patient with Multiple SclerosisToshio Inui, Goro Katsuura, Kentaro Kubo, et al.
Journal of Radiation Research|January 6, 2006
Reevaluation of the radiosensitizing effects of sanazole and nimorazole in vitro and in vivoChikao Sugie, Yuta Shibamoto, Masato Ito, et al.
Anticancer Research|June 30, 2016
Macrophages Exhibit a Large Repertoire of Activation States via Multiple Mechanisms of Macrophage-activating FactorsY U Sumiya, Takahiro Inoue, Mami Ishikawa, et al.
Journal of Cancer Research and Clinical Oncology|August 23, 2006
Dependency of the effect of a vascular disrupting agent on sensitivity to tirapazamine and gamma-ray irradiation upon the timing of its administration and tumor size, with reference to the effect on intratumor quiescent cellsShin-ichiro Masunaga, Hideko Nagasawa, Kenji Nagata, et al.
Pageof 14